DFS analysis results showed that SLC2A1 was a risk factor in ACC (HR = 3.966, p = 0.047), COAD (HR = 3.166, p = 0.016), LUAD (HR = 1.704, p = 0.014) and PAAD (HR = 3.600, p = 0.007) (Figure 7B). Here, SLC2A1 is linked to adrenal cortex carcinoma.